PATENT CLAIM ANALYSIS

Application Number: 15564531
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-05
Patent Classification: ["514", "629000"]

Abstract:
The present invention relates to methods and compositions for treating heart failure in a subject using histone deacetylase (HDAC) inhibitors and/or histone acetyltransferases (HAT) activators.

Claim (Index 1):
A method of increasing expression of Brg1 and/or Brm mRNA and/or BRG1 and/or BRM protein in a subject, comprising delivering to the subject an effective amount of a histone deacetylase (HDAC) inhibitor and/or a histone acetyltransferase (HAT) activator, thereby increasing expression of Brg1 and/or Brm mRNA and/or BRG1 and/or BRM protein in the subject.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11365268', '14777211', '14884827', '14650473', '12851610']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.718460844513268
- 35 USC 102 Novelty (BERT): 0.5274537188477426
- Combined Prediction Score: 0.6993601319467154
- Mean Citation Score: 264.59926
- Max Citation Score: 313.5870700000001
- Similarity Product: 210.4904378364176

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test